Kemal Malik
Director/Board Member at SYNCONA LIMITED
Net worth: 18 018 $ as of 30/04/2024
Kemal Malik active positions
Companies | Position | Start | End |
---|---|---|---|
SYNCONA LIMITED | Director/Board Member | 15/06/2020 | - |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam. | Director/Board Member | - | - |
Career history of Kemal Malik
Former positions of Kemal Malik
Companies | Position | Start | End |
---|---|---|---|
BAYER AG | Corporate Officer/Principal | 01/02/2014 | 31/12/2019 |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Director/Board Member | - | 01/02/2014 |
Chief Tech/Sci/R&D Officer | - | 01/02/2014 | |
ACCELERON PHARMA INC. | Director/Board Member | 01/01/2020 | - |
Independent Dir/Board Member | 01/01/2020 | - | |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | - | - |
Northwick Park Institute For Medical Research
Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Northwick Park Institute For Medical Research is a charity-based independent medical research institute. The private company is based in Middlesex, UK. The British company was founded in 1994. | Corporate Officer/Principal | - | - |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Chief Tech/Sci/R&D Officer | 27/07/2009 | - |
Training of Kemal Malik
University of London | Undergraduate Degree |
Statistics
International
United Kingdom | 7 |
Germany | 4 |
United States | 2 |
Operational
Corporate Officer/Principal | 4 |
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BAYER AG | Health Technology |
Private companies | 7 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
Syncona Ltd.
Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Syncona Ltd. is a closed-end investment fund. It engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. The company was founded on August 14, 2012, and is headquartered in St. Peter Port, the United Kingdom. | Miscellaneous |
Northwick Park Institute For Medical Research
Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Northwick Park Institute For Medical Research is a charity-based independent medical research institute. The private company is based in Middlesex, UK. The British company was founded in 1994. | Commercial Services |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam. | Commercial Services |
- Stock Market
- Insiders
- Kemal Malik
- Experience